Weekly Spotlight
The Trump administration released its fiscal year 2027 budget request this week, and for health care stakeholders, the document is less a spending plan than a statement of intent. The proposal calls for a 12% cut to the Department of Health and Human Services (HHS)—a reduction that, if enacted, would represent one of the largest single-year contractions in the department’s history. At its center is a $5 billion reduction to the National Institutes of Health (NIH), including the outright elimination of several research institutes. The Centers for Disease Control and Prevention (CDC) Injury Center, which has survived prior elimination attempts, is again on the chopping block.
The budget arrives as HHS is already operating well below capacity. One year after sweeping layoffs, the department remains in disarray, with thousands of positions unfilled and institutional knowledge gone. CMS is attempting to implement major new policies—including Medicaid work requirements—with a significantly diminished workforce. Proposing further cuts to an agency already stretched thin adds a layer of operational risk the budget document does not address.
Within the proposal, priorities are not evenly distributed. FDA emerges relatively unscathed, consistent with the administration’s stated emphasis on accelerating drug and device approvals. CMS’s requested funding targets Medicare claims processing modernization, Medicaid data systems, and program integrity—areas that align with the administration’s Medicaid work requirement push and its broader effort to tighten eligibility. HHS reorganization, announced earlier this year, is reiterated as a structural goal.
The political math is complicated. Congress largely ignored the administration’s fiscal year 2026 budget proposal, and there is little reason to expect a different outcome here. Republican lawmakers have already shown significant reluctance to absorb deep Medicaid cuts as part of other legislative priorities, and a budget that doubles down on HHS reductions is unlikely to find smooth passage. The document functions, in practice, as a political signal rather than a legislative blueprint.
What makes this week’s release notable is its timing. The budget dropped as 130-plus hospitals are suing HHS over payment methodology, the CDC is pausing diagnostic testing for dozens of infectious diseases, and the federal health workforce is still recovering from last year’s mass layoffs. Taken together, the picture is of a federal health apparatus under simultaneous budget, legal, and operational pressure—with the administration proposing to reduce its capacity further.
For health policy practitioners, the practical question is less whether this budget passes and more what it signals about the negotiating floor. Proposals that start at a 12% HHS cut and $5 billion in NIH reductions set a baseline from which any eventual compromise will be measured. That baseline, and what Congress is willing to defend, will define the contours of health funding for the next fiscal year.
Tags: #PATIENT #PAYER #PROVIDER #HOSPITAL
Centers for Medicare and Medicaid Services (CMS)
CMS Launches LEAD Model Applications Amid GAO Scrutiny of Innovation Center Track Record
CMS opened applications on March 31 for its Long-term Enhanced ACO Design (LEAD) model, with a performance period beginning January 2027. The model requires accountable care organizations to incorporate interoperability, telehealth, artificial intelligence, and wearable devices into care coordination. The announcement came as a GAO audit found the CMS Innovation Center spent $7.9 billion over a decade but scaled up very few models to broader Medicare, drawing renewed Republican scrutiny. The Congressional Budget Office has also estimated that CMMI has produced limited net savings to date.
Source(s):
CMS LEAD Model Incorporates Telehealth, AI, Wearables, Interoperability
CMS requests ACOs apply for LEAD model
CMMI Under Scrutiny as CMS Launches LEAD Model and GAO Reports Limited Scale-Ups
Tags: #PROVIDER #PAYER
More Than 130 Hospitals Sue HHS Over Disproportionate Share Payment Methodology
More than 130 hospitals across 16 states have filed suit against HHS over a 2023 final rule they argue systematically underpays facilities serving disproportionate shares of low-income patients. The hospitals seek a return to pre-2004 Disproportionate Share Hospital payment calculation standards and back payments they contend are owed. The litigation adds to a growing body of hospital-federal payment disputes under the current administration.
Source(s):
Hospitals sue HHS over Disproportionate Share Hospital payments
Over 130 hospitals sue HHS over DSH payments
Tags: #HOSPITAL
Bipartisan Pressure Mounts on Medicare Advantage Overpayments as CMS Awards New Review Contract
Bipartisan senators praised CMS’s proposal to exclude diagnoses from unlinked chart reviews as a step toward curbing Medicare Advantage overpayments, but urged the agency to pursue additional tools and called on Congress to act further. Some lawmakers argued CMS’s projected savings from the proposal are too conservative. Separately, CMS awarded its MA independent review entity contract to C2C Innovative Solutions, replacing its prior vendor as the agency continues to build out its Medicare Advantage oversight infrastructure.
Source(s):
Bipartisan lawmakers urge CMS to crack down on Medicare Advantage overpayments
Bipartisan Sens Praise CMS’ MA Chart Review Proposal, Say Congress Should Go Further
CMS awards MA independent review contract to new vendor
Tags: #PAYER #PROVIDER
CMS Finalizes Medicare Advantage Star Ratings Overhaul, Adding $18.6 Billion in Bonus Payments
CMS finalized sweeping changes to its Medicare Advantage and Part D star ratings system, reducing the number of measures used to grade plans and eliminating health equity requirements. The changes are projected to add $18.6 billion in bonus payments to MA plans over the next decade. CMS said the overhaul will encourage high performance across all areas of care; the special enrollment window provision included in an earlier proposal was not finalized. The Blue Cross Blue Shield Association separately called on CMS to address fraud gaps and regulate AI-assisted coding in Medicare Advantage.
Source(s):
CMS finalizes Medicare Advantage star ratings overhaul, sending billions of dollars more to insurers
Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures
CMS finalizes Medicare Advantage Star Ratings overhaul for 2027
InsideHealthPolicy
Fierce Healthcare
Tags: #PAYER
Insurer Prior Authorization Data Goes Public, But Analysis Finds Limited Transparency
Health insurers are now required to publicly post prior authorization metrics under federal rules, and most have complied. A KFF analysis of the newly released data found significant variation in how insurers report and categorize denials, limiting its usefulness for assessing actual denial patterns. CMS also proposed implementing prior authorization for select Medicare services while delaying certain other requirements.
Source(s):
Payers’ prior authorization denial rates go public: 5 notes
MedPage Today
Tags: #PAYER #PROVIDER #PATIENT
Trump’s Hunt for Undocumented Medicaid Enrollees Yields Few Violators
Federal immigration-status reviews of Medicaid enrollees across five states found very few ineligible recipients: Pennsylvania and Colorado found no ineligible enrollees among 79,000 names reviewed, while Texas, Ohio, and Utah terminated only 379 out of approximately 101,000 reviewed. The findings raise questions about the efficacy and cost-justification of mandatory eligibility reviews initiated under the Trump administration’s immigration enforcement push.
Source(s): Trump’s Hunt for Undocumented Medicaid Enrollees Yields Few Violators
Tags: #PATIENT #PAYER
How Medicaid Contractors Stand to Gain From Trump’s Policy
States are paying Deloitte, Accenture, Optum, and other contractors millions to update eligibility systems to comply with new Medicaid work requirements under federal law. The contractors stand to benefit significantly as states race to implement the policy changes.
Source(s): How Medicaid Contractors Stand to Gain From Trump’s Policy
Tags: #PAYER #PATIENT
CMS Proposes Payment Rules for Four Care Settings
CMS released four proposed payment rules covering skilled nursing facilities, inpatient rehabilitation facilities, home health agencies, and hospice providers for fiscal year 2027. The rules outline reimbursement rates and quality reporting requirements across each care setting.
Source(s): CMS Proposes Payment Rules for Four Care Settings
Tags: #HOSPITAL #PROVIDER
Food and Drug Administration (FDA)
‘Cracks Show’ as CDRH Staff Contend With Heavy Workloads
A joint investigation by Healthcare Dive and MedTech Dive finds that experienced staff are leaving FDA’s Center for Devices and Radiological Health (CDRH) amid a reported culture of fear and anxiety, with remaining employees facing mounting workloads. Former device center leaders warn the situation is eroding the agency’s regulatory capacity at a time of growing demand for device approvals and AI tool oversight.
Source(s): ‘Cracks Show’ as CDRH Staff Contend With Heavy Workloads
Tags: #DEVICE
FDA’s Breakthrough Device Designation Increasingly Favors Broad AI Platforms Over Single-Task Tools
An analysis of AI-powered medical devices that have received FDA’s breakthrough device designation shows the agency favors broad, multi-problem AI platforms over detection-only tools. The trend has implications for how AI developers structure regulatory submissions and for how downstream Medicare coverage and payment decisions may shape the clinical AI market.
Source(s):
FDA’s evolving view of what makes a ‘breakthrough’ device
Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ device?
Tags: #DEVICE #PROVIDER
Speeding Up Approvals, Getting More Drugs OTC Among FDA’s Top Priorities
FDA leadership has outlined accelerating drug approvals and expanding over-the-counter drug availability as top priorities for 2026. The agency is directing increased resources toward OTC switch applications and streamlining the approval process to reduce barriers to self-care.
Source(s): Speeding Up Approvals, Getting More Drugs OTC Among FDA’s Top Priorities
Tags: #DRUG #PATIENT
FDA Approves Eli Lilly’s Oral GLP-1 Drug Foundayo for Weight Loss; Novo Nordisk Responds
The FDA approved Eli Lilly’s orforglipron, marketed as Foundayo, as the second oral glucagon-like peptide-1 (GLP-1) receptor agonist indicated for weight loss in adults with obesity or overweight with a related comorbidity. The pill-form therapy offers a needle-free alternative to injectable GLP-1 drugs and positions Lilly to compete directly with Novo Nordisk in the rapidly expanding oral obesity drug market. Novo Nordisk responded with statements about its own oral pipeline, including data showing its Wegovy pill achieved greater weight loss than orforglipron in comparative analysis, signaling an intensifying competitive dynamic.
Source(s):
New GLP-1 Pill Wins Speedy Approval for Weight Loss
F.D.A. Approves New Eli Lilly Weight-Loss Pill, Foundayo
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Tags: #DRUG #PATIENT #PAYER
Cardiac Device Roundup
Several cardiovascular device developments emerged from the ACC.26 annual meeting and related clinical data this week.
- JenaValve launches Trilogy TAVR system in the US
- TEER system may reduce heart failure hospitalization risk
- Edwards shares data on tricuspid valve replacement
- Study supports label expansion for Boston Scientific device
- J&J’s Impella heart pump showed no patient benefit in two randomized trials at ACC.26, leading investigators to caution against its routine use in complex percutaneous coronary interventions. Sources: J&J’s Impella heart pump shows no patient benefit in 2 trials
Tags: #DEVICE #PROVIDER
Biopharma R&D Pipeline Shrinks for First Time in 30 Years
The number of drugs in development has fallen for the first time since the mid-1990s, according to a new industry report. The contraction signals potential shifts in pharmaceutical investment and development strategy.
Source(s): Biopharma R&D Pipeline Shrinks for First Time in 30 Years
Tags: #DRUG
Department of Health and Human Services (HHS)
Trump Says It Is ‘Not Possible’ for Federal Government to Manage Daycare, Medicaid, and Medicare
President Trump stated publicly that it is ‘not possible’ for the federal government to manage daycare, Medicaid, and Medicare programs, signaling a broader ideological push toward devolving social programs to states or private entities. The remarks accompanied criticism of Medicaid fraud found in Minnesota and promotion of Vice President JD Vance’s childcare policy efforts.
Source(s): Trump Says It Is ‘Not Possible’ for Federal Government to Manage Daycare, Medicaid, and Medicare
Tags: #PATIENT #PAYER
HHS Reorganizes ONC, Reversing Assistant Secretary Title
HHS published a Federal Register notice reorganizing the Office of the National Coordinator for Health Information Technology (ONC), reversing the administrative actions that created the title of Assistant Secretary for Technology Policy. The change represents a structural reduction in ONC’s administrative authority within HHS.
Source(s): HHS Reorganizes ONC, Reversing Assistant Secretary Title
Tags: #PROVIDER
CDC Pauses Diagnostic Testing for Rabies and Dozens of Infectious Diseases
The CDC paused diagnostic testing for rabies and dozens of other infectious diseases, including monkeypox, effective April 2, 2026. The scale of affected diseases has not been fully disclosed, raising concerns among public health practitioners about gaps in outbreak detection. The pause is linked to ongoing staffing reductions and operational restructuring at the agency.
Source(s):
CDC Pauses Testing for Rabies and Dozens of Other Infectious Diseases
Tags: #PATIENT #PROVIDER
Ryan White: The Safety Net We Cannot Afford to Shrink
Dr. Daskalakis writes in Medscape about the Ryan White HIV/AIDS Program’s critical role as a safety net for vulnerable patients, highlighting significant strides in HIV/AIDS treatment and warning against reducing program funding at a time when access to care remains essential.
Source(s): Ryan White: The Safety Net We Cannot Afford to Shrink
Tags: #PATIENT #PROVIDER
Subscription Pricing Model Could Expand Access to HIV Prevention Drug Lenacapavir
Analysts and advocates argue that subscription-based pricing for lenacapavir, a long-acting injectable proven highly effective at HIV prevention, could make the drug more accessible to public payers and underserved populations while controlling program costs. The model could accelerate progress toward ending the HIV epidemic if affordability barriers are adequately addressed.
Source(s):
Subscription Pricing Could Expand Access to HIV Prevention Breakthrough
Opinion: Subscription pricing could expand HIV prevention access
Tags: #DRUG #PATIENT #PAYER
HHS Takes First Step Toward Restoring Vaccine Advisory Committee
HHS is taking initial steps to reconstitute its vaccine advisory committee after a federal judge questioned the panel’s legitimacy and overturned its prior composition. The move signals a partial course correction on vaccine policy under the Kennedy-led HHS.
Source(s): HHS Takes First Step Toward Restoring Vaccine Advisory Committee
Tags: #ALL
Health System Faces Compounding Workforce Pressures From HHS Layoffs, Visa Delays, and CMS Staffing Gaps
One year after large-scale HHS reductions, the department remains in disarray with thousands of positions unfilled and experienced institutional knowledge lost across key programs. CMS is simultaneously undertaking major policy initiatives, including implementing Medicaid work requirements, with a significantly diminished staff. A separate visa processing slowdown is forcing foreign-trained physicians from countries designated as national security threats to face professional limbo as renewal applications go unanswered.
Source(s):
A slowdown in US visa processing is wreaking havoc on foreign doctors’ lives
CMS tackles big policy changes with diminished workforce
One year after HHS layoffs, a department in disarray
Tags: #PROVIDER #HOSPITAL
Kennedy to Appear Before Six Congressional Committees in April
HHS Secretary Robert F. Kennedy Jr. is scheduled to appear before six congressional committees in April. The hearings are expected to cover HHS operations, budget priorities, and the department’s ongoing reorganization.
Source(s): Kennedy to Appear Before Six Congressional Committees in April
Tags: #PROVIDER #HOSPITAL
Heard on the Hill
Trump Signs Executive Order Imposing Up to 100% Tariffs on Imported Patented Drugs
President Trump signed an executive order imposing tariffs as high as 100% on imported patented pharmaceutical products, while carving out exceptions for drugs participating in the Most Favored Nation pricing program and exempting generics and biosimilars. Industry groups warned the tariffs could raise drug costs for consumers and disrupt global supply chains. Small drugmakers have begun negotiating pricing deals to seek relief from tariff impacts.
Source(s):
Trump Plans Tariffs on Patented Drugs, Carving Out MFN Participants and Generic, Biosimilar Drugmakers
Trump announces tariffs as high as 100% on pharmaceuticals
MedPage Today
Fierce Biotech
Tags: #DRUG #PAYER #PATIENT
Health Care Cuts Emerge as Central Complication in Republican Budget Reconciliation Push
Proposed Medicaid and other health program reductions are creating significant political friction within the Republican caucus as Congress works to advance reconciliation legislation funding immigration enforcement and other Trump administration priorities. The scale of the proposed cuts has stalled the broader package, and reporting indicates the GOP is considering additional health reductions to meet budget targets.
Source(s):
STAT+: How Health Care Could Gum Up Trump’s Reconciliation Push
KFF Health News: GOP Mulls More Health Cuts
Tags: #PAYER #PATIENT
Save Struggling Hospitals Act Would Restore CMS Wage Index Policy
The bipartisan Save Struggling Hospitals Act would restore a CMS wage index policy for low-wage hospitals, addressing financial distress at rural and underserved facilities.
Source(s): Save Struggling Hospitals Act Would Restore CMS Wage Index Policy
Tags: #HOSPITAL #PROVIDER
Drug-Pricing Middlemen Push Back on Reforms
Pharmacy benefit managers (PBMs) are mounting a coordinated defense against bipartisan reform efforts that have gained momentum in Washington. PBM industry groups argue proposed changes would disrupt the drug supply chain and increase patient costs, while critics counter that current PBM practices inflate drug prices and obscure pricing transparency for employers and plan sponsors.
Source(s): Drug-Pricing Middlemen Push Back on Reforms
Tags: #DRUG #PAYER #PATIENT
Trump FY2027 Budget Proposes 12% Cut to HHS, Including $5 Billion NIH Reduction
The White House released its fiscal year 2027 budget request proposing approximately 12.5% cuts to HHS and a $5 billion reduction to the National Institutes of Health, including eliminating three research institutes. The proposal reiterates plans for HHS reorganization and targets the CDC Injury Center for elimination. Congress largely ignored the administration’s previous budget proposal, and lawmakers are expected to push back significantly on these reductions as well.
Source(s):
Trump health budget offers investments in MAHA, cuts to HHS, NIH
White House seeks 12% cut to HHS in 2027
White House floats 12.5% budget cut for HHS in FY2027, reiterates reorganization plan
Modern Healthcare
POLITICO Pulse
Tags: #PATIENT #PAYER
Notable Notes
Outlook 2026: Regulatory Uncertainty, Evidence Evolution, and the Future of Health Technology Assessment
Health Management Associates examines major regulatory and policy pressures shaping healthcare innovation in 2026, covering drug development, coverage frameworks, and payment policy. The analysis highlights how evolving evidence standards and regulatory uncertainty are affecting health technology assessment decision-making across payers and developers.
Source(s): Outlook 2026: Regulatory Uncertainty, Evidence Evolution, and the Future of Health Technology Assessment
Tags: #DRUG #PAYER
Cancer Screening Costs Rival Diagnosis Fears as Patients Fall Behind
Americans are increasingly skipping cancer screenings, and a growing share report that concern about the financial cost of a positive diagnosis deters them from getting screened. The finding highlights cost as a compounding access barrier in preventive care, with implications for payer coverage policy and patient outreach.
Source(s): Cancer Screening Costs Rival Diagnosis Fears as Patients Fall Behind
Tags: #PATIENT #PAYER
When Shared Decision-Making Becomes Medical Paternalism
A MedPage Today opinion piece examines the tension between shared decision-making and medical paternalism in clinical care, using end-of-life feeding tube discussions as a case study. The author argues that overreliance on structured consent processes can obscure rather than surface patient values.
Source(s): When Shared Decision-Making Becomes Medical Paternalism
Tags: #PROVIDER #PATIENT
Leapfrog Group to Expand ASC Public Reporting Program to Nearly 4,000 Facilities
The Leapfrog Group is expanding its Ambulatory Surgery Center (ASC) Public Reporting Program to include nearly 4,000 ASCs across the U.S., significantly broadening public transparency about safety and quality in outpatient surgical settings. The expansion increases patient access to comparative quality data as more procedures shift to the ASC setting.
Source(s): Leapfrog Group to Expand ASC Public Reporting Program to Nearly 4,000 Facilities
Tags: #HOSPITAL #PATIENT
Women Face Longer Peer Review Delays
A PLOS Biology analysis finds papers led by women spend 7%-15% longer in peer review than those led by men, a disparity with potential career advancement implications in academic medicine and research.
Source(s): Women Face Longer Peer Review Delays
Tags: #PROVIDER